MEMY Memory Pharmaceuticals Corp (MM)

MONTVALE, N.J., Nov. 6 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (NASDAQ:MEMY) announced today that it will report its third quarter 2008 financial results on Thursday, November 13, 2008 before the U.S. financial markets open. Management will provide a Company update and discuss the third quarter results during a conference call the same day, at 9:00 a.m. EST. Investors and other interested parties may access the call as follows: Date: Thursday, November 13, 2008 Time: 9:00 a.m. EST Telephone (U.S.): 866.543.6407 Telephone (international): 617.213.8898 Participant Passcode: 22960486 Webcast: http://www.memorypharma.com/ under the "Investors" section An audio replay of the conference call will be available from 11:00 a.m. EST on Thursday, November 13, 2008, until Thursday, November 20, 2008. To access the replay, please dial 888.286.8010 (U.S.) or 617.801.6888 (international) and enter pass code number 92102882. An audio replay of the conference call will also be available under the "Investors" section of the Company's website during the same period. About Memory Pharmaceuticals Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders, many of which exhibit significant impairment of memory and other cognitive functions, including Alzheimer's disease and schizophrenia. For additional information, please visit our website at http://www.memorypharma.com/. DATASOURCE: Memory Pharmaceuticals Corp. CONTACT: Jzaneen Lalani, General Counsel, +1-201-802-7249, or Laura Perry, LMP Investor Relations Inc., +1-646-719-1055, both for Memory Pharmaceuticals Corp. Web Site: http://www.memorypharma.com/

Copyright